- Home
- STTK vs IONR Comparison
STTK vs IONR Comparison
Compare STTK & IONR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STTK
- IONR
- Stock Information
- Founded
- STTK 2016
- IONR 2001
- Country
- STTK United States
- IONR Australia
- Employees
- STTK N/A
- IONR N/A
- Industry
- STTK Biotechnology: Pharmaceutical Preparations
- IONR
- Sector
- STTK Health Care
- IONR
- Exchange
- STTK Nasdaq
- IONR Nasdaq
- Market Cap
- STTK 56.8M
- IONR 319.2M
- IPO Year
- STTK 2020
- IONR N/A
- Fundamental
- Price
- STTK $1.12
- IONR $4.11
- Analyst Decision
- STTK Hold
- IONR
- Analyst Count
- STTK 3
- IONR 0
- Target Price
- STTK $2.00
- IONR N/A
- AVG Volume (30 Days)
- STTK 182.2K
- IONR 25.0K
- Earning Date
- STTK 02-27-2025
- IONR 01-01-0001
- Dividend Yield
- STTK N/A
- IONR N/A
- EPS Growth
- STTK N/A
- IONR N/A
- EPS
- STTK N/A
- IONR N/A
- Revenue
- STTK $6,435,000.00
- IONR N/A
- Revenue This Year
- STTK $313.04
- IONR N/A
- Revenue Next Year
- STTK N/A
- IONR N/A
- P/E Ratio
- STTK N/A
- IONR N/A
- Revenue Growth
- STTK 382.75
- IONR N/A
- 52 Week Low
- STTK $0.94
- IONR $2.90
- 52 Week High
- STTK $11.76
- IONR $9.35
- Technical
- Relative Strength Index (RSI)
- STTK 43.75
- IONR 42.24
- Support Level
- STTK $1.13
- IONR $3.71
- Resistance Level
- STTK $1.39
- IONR $4.58
- Average True Range (ATR)
- STTK 0.11
- IONR 0.34
- MACD
- STTK 0.00
- IONR 0.07
- Stochastic Oscillator
- STTK 18.18
- IONR 51.04
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.
About IONR ioneer Ltd
Ioneer Ltd is a mineral exploration company. The company's focus is on the Rhyolite Ridge Lithium-Boron Project located in Nevada, USA. Geographically, the group has a business presence in Australia and North America. The company's focus is to develop a U.S.-based source of lithium and boron that can be extracted in an environmentally and socially responsible manner, providing two materials that are essential to achieve a sustainable future for the planet.